IRAD2 : Patients With Respiratory Failure at Home

Status Completed

Clinical Trial Summary

Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion.

This is a randomized controlled, open clinical trial with two groups.

- first group, 100 patients : control group, patients followed with no add-on intervention

- Second group, 100 patients : rehabilitation group with education, oral supplements, exercise and androgenic steroids.

Clinical Trial Description

Title : Effects of home pulmonary rehabilitation in patients with chronic respiratory failure and nutritional depletion

State of the art :

The IRAD2 trial is evaluating a 3-month home intervention which includes education, oral supplements, exercise and androgenic steroids in undernourished patients with chronic respiratory failure. The main objective is to increase the six-minute walking distance by more than 50 m with an improvement in health-related quality-of-life. Secondary end-points include a reduction in exacerbation rates by 25%, a reduction in health-related costs and an increase in survival during the year following intervention.

Material and methods :

This interventional, multi-centre, prospective, two-armed parallel, controlled trial is being conducted in 200 patients. In both groups, "Control" and "Rehabilitation", 7 home visits are scheduled during the 3-month intervention for education purpose. In the "Rehabilitation" group, patients will receive 160 mg/d of oral testosterone undecanoate in men, 80 mg/d in women, oral dietary supplements (563 kcal/d) and exercises on an ergometric bicycle 3 to 5 times a week.

Expected results :

In the event of significant responses to intervention, this trial would validate a comprehensive and global home-care for undernourished patients with chronic respiratory failure combining therapeutic education, oral supplements, androgenic substitution and physical activity. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00230984
Study type	Interventional
Source	University Hospital, Grenoble
Contact
Status	Completed
Phase	Phase 3
Start date	April 2003
Completion date	June 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05084976` - Parental Perception of COVID-19 Vaccine in Technology Dependent Patients
Not yet recruiting	`NCT05756387` - Improving Chronic Nocturnal Noninvasive Ventilation: a Multimodality Approach
Enrolling by invitation	`NCT04208581` - Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure	Phase 3
Recruiting	`NCT02260583` - Effect of Extracorporeal CO2 Removal in Stable Hypercapnic COPD Patients	N/A
Completed	`NCT01255111` - Adaptation to Nocturnal Noninvasive Ventilation in Patients With Chronic Respiratory Failure (ROOMILA)	N/A
Active, not recruiting	`NCT03499470` - Structured Discharge and Follow-up Protocol for COPD Patients Receiving LTOT and NIV	N/A
Completed	`NCT04143230` - Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool	N/A
Terminated	`NCT00208078` - Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.	Phase 4
Recruiting	`NCT06286917` - Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency	N/A
Completed	`NCT02342899` - Cost Effectiveness of Outpatient Set-up of Automated NIV in Obese Patients With Chronic Respiratory Failure	Phase 3
Terminated	`NCT03473171` - Implementation of Nasal Non-Invasive Ventilation With a RAM Cannula in the Inpatient /Outpatient Setting	N/A
Not yet recruiting	`NCT05258370` - Fibroblast Growth Factor 23 in Chronic Respiratory Failure
Completed	`NCT02804243` - The Efficacy of Nasal High Flow Oxygen Therapy With Rehabilitation in the Patients With Chronic Respiratory Failure	N/A
Completed	`NCT01479959` - Impact of Patient Controlled Positive End-expiratory Pressure on Speech in Tracheostomized Ventilated Patients	N/A
Completed	`NCT01090986` - Home Mechanical Ventilation Effectiveness and Air Leaks	N/A
Completed	`NCT00698958` - Ambulatory Adaptation to Non-Invasive Mechanical Ventilation	Phase 4
Not yet recruiting	`NCT06119087` - Mechanical Insufflation in the Philadelphia Amyotrophic Lateral Sclerosis Cohort (MI-PALS) Study	N/A
Recruiting	`NCT05796297` - Clinical Impact of Patient-ventilator Asynchrony
Recruiting	`NCT04481295` - Study on Optimal Oxygen Concentration During Pulmonary Rehabilitation	N/A
Withdrawn	`NCT05379439` - Family Connections	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.